NCT05649709View on ClinicalTrials.gov

Helicobacter Pylori and Vonoprazan Dual Therapy

PHASE4CompletedINTERVENTIONAL
Enrollment

504

Participants

Timeline

Start Date

February 13, 2023

Primary Completion Date

January 25, 2024

Study Completion Date

January 25, 2024

Conditions
Helicobacter Pylori
Interventions
DRUG

L-VA dual therapy

1000mg amoxicillin capsules twice times daily and 20mg vonoprazan Fumarate Tablets twice daily for 14 days

DRUG

H-VA dual therapy

1000mg amoxicillin capsules three times daily and 20mg vonoprazan Fumarate Tablets twice daily for 14 days

Trial Locations (1)

330006

The First Affiliated Hospital Of Nanchang University, Nanchang

All Listed Sponsors
lead

The First Affiliated Hospital of Nanchang University

OTHER